| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | EP0824527A1 Quinazoline derivatives |
| 02/25/1998 | EP0824526A1 Quinazoline derivative |
| 02/25/1998 | EP0824525A1 Quinazoline derivatives |
| 02/25/1998 | EP0824350A1 Antifungal composition |
| 02/25/1998 | EP0705259B1 Phenyrrole derivatives and their use as dopamine d3 antagonists |
| 02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
| 02/25/1998 | CN1174192A New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them |
| 02/25/1998 | CN1174081A 'Longteng' medicinal wine |
| 02/25/1998 | CN1037512C Imidazolyl-substituted cyclohexane derivatives, prep. and use thereof |
| 02/24/1998 | US5721356 Orally active adenosine kinase inhibitors |
| 02/24/1998 | US5721337 Human thymosin β15 |
| 02/24/1998 | US5721276 Treating disorders of melatoninergic system |
| 02/24/1998 | US5721260 Heterocyclic compounds |
| 02/24/1998 | US5721256 Inhibitors of the enzyme activity associated with immunophilin proteins |
| 02/24/1998 | US5721254 Antiinflammatory agents; analgesics |
| 02/24/1998 | US5721249 Administering to treat angina |
| 02/24/1998 | US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 02/24/1998 | US5721241 Enzyme inhibitors, their synthesis, and methods for use |
| 02/24/1998 | US5721240 9-substituted-8-unsubstituted-9-deazaguanines |
| 02/24/1998 | US5721238 2,8-disubstituted quinazolinones |
| 02/24/1998 | US5721237 Administering for the selective treatment of cell growth and differentiation |
| 02/24/1998 | US5721225 Skin disorders; osteoporosis |
| 02/24/1998 | US5721224 Method of treating metabolic bone diseases with 18-nor-vitamin D compounds |
| 02/24/1998 | US5721107 Antibodies to G protein coupled glutamate receptors |
| 02/24/1998 | US5720977 Oral water soluble pharmaceutical compositions containing estrone compound and calcium salt |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | CA2043071C Heterocyclic compounds |
| 02/21/1998 | CA2213361A1 Stable, long acting salts of carboxamides for the treatment of joint disease |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
| 02/19/1998 | WO1998006747A2 Uses for wnt polypeptides |
| 02/19/1998 | WO1998006743A1 Acylated peptide cytolytic peptide inhibitors |
| 02/19/1998 | WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006730A1 Modified oligosaccharides |
| 02/19/1998 | WO1998006722A1 Thienopyrimidines |
| 02/19/1998 | WO1998006716A1 Preparation of aminomethyl-phenylimidazoles |
| 02/19/1998 | WO1998006715A1 Novel piperazine containing compounds |
| 02/19/1998 | WO1998006711A1 Butyric acid matrix metalloproteinase inhibitors |
| 02/19/1998 | WO1998006708A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 02/19/1998 | WO1998006705A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 02/19/1998 | WO1998006704A1 Arylalkanoyl pyridazines |
| 02/19/1998 | WO1998006700A1 Stereoselective deoxygenation reaction |
| 02/19/1998 | WO1998006406A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders |
| 02/19/1998 | WO1998006400A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 02/19/1998 | WO1998006399A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006398A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006396A1 Thrombin inhibitors |
| 02/19/1998 | WO1998006394A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | WO1998006392A1 Formulation of 5-ht agonists |
| 02/19/1998 | WO1997049805A3 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | WO1997046208A3 Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| 02/19/1998 | DE19632772A1 Neue Benzamidine New benzamidines |
| 02/19/1998 | DE19632549A1 Arylalkanoylpyridazine Arylalkanoylpyridazine |
| 02/19/1998 | DE19632423A1 Thienopyrimidine Thienopyrimidines |
| 02/19/1998 | CA2264104A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 02/19/1998 | CA2263789A1 Acylated peptide cytolytic peptide inhibitors |
| 02/19/1998 | CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
| 02/19/1998 | CA2263163A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2262686A1 Thrombin inhibitors |
| 02/19/1998 | CA2262676A1 Stereoselective deoxygenation reaction |
| 02/19/1998 | CA2261752A1 Preparation of aminomethyl-phenylimidazoles |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/19/1998 | CA2260872A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 02/19/1998 | CA2260854A1 Modified oligosaccharides |
| 02/18/1998 | EP0824098A1 4-hydroxy-piperidine derivatives |
| 02/18/1998 | EP0823942A1 Efflux pump inhibitors |
| 02/18/1998 | EP0823908A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823905A1 Novel heterocyclic chemistry |
| 02/18/1998 | EP0823901A1 Quinazoline derivative |
| 02/18/1998 | EP0823900A1 Quinazoline derivatives |
| 02/18/1998 | EP0823896A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823893A1 Novel tetracycline derivatives |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | EP0719252B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 02/18/1998 | EP0719148B1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 02/18/1998 | EP0675900B1 Antibiotics ge 37468 a, b and c |
| 02/18/1998 | EP0561939B1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 02/18/1998 | CN1173874A Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compsns containing same |
| 02/18/1998 | CN1173819A Methods of inhibiting effects of IL_6 |
| 02/18/1998 | CN1173500A PEG-interferon conjugates |
| 02/18/1998 | CN1173497A Heterocycle-containing carbonic acid derivatives |
| 02/18/1998 | CN1173339A 百年乐口服液及其制备方法和应用 Oral century music and its preparation method and application |
| 02/18/1998 | CN1173330A Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors |
| 02/18/1998 | CN1173328A Use of medicinal feed for systemic treatment of fish diseases |
| 02/18/1998 | CN1037440C Method for prepn. of angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones |
| 02/17/1998 | US5719306 LTA4 hydrolase inhibitors |
| 02/17/1998 | US5719287 Intermediates for inhibitors of HIV protease and method of preparation thereof |
| 02/17/1998 | US5719189 Containing triphenylmethane |
| 02/17/1998 | US5719185 Use for GABA agonists for treating emesis |
| 02/17/1998 | US5719184 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
| 02/17/1998 | US5719175 Protein kinase C inhibitors |